Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations

Human Genomics

Volumn 6, Issue 1, 2012, Pages

  Elhawy, Eman ^a   Kamthan, Gautam ^b   Dong, Cecilia Q ^a   Danias, John ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Exfoliation; Genetics; Glaucoma; LOXL1; Pseudoexfoliation syndrome

Indexed keywords

ADENOSINE RECEPTOR; CLUSTERIN; COLLAGEN; ELASTIN; GLUTATHIONE TRANSFERASE; INTERSTITIAL COLLAGENASE; LYSYL OXIDASE LIKE 1; MESSENGER RNA; PROTEIN LYSINE 6 OXIDASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADENOSINE A3 RECEPTOR; LOXL1 PROTEIN, HUMAN; MMP1 PROTEIN, HUMAN; OXIDOREDUCTASE;

CLINICAL FEATURE; CONNECTIVE TISSUE; CROSS LINKING; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; EYE DISEASE; GENETIC DISORDER; GLAUCOMA; HAPLOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; OPEN ANGLE GLAUCOMA; PSEUDOEXFOLIATION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SYSTEMIC DISEASE; TRANSMISSION ELECTRON MICROSCOPY; CHROMOSOME 15; EYE; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; METABOLISM; PATHOPHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID OXIDOREDUCTASES; CHROMOSOMES, HUMAN, PAIR 15; CLUSTERIN; COLLAGEN; ELASTIN; EXFOLIATION SYNDROME; EXTRACELLULAR MATRIX; EYE; GENE-ENVIRONMENT INTERACTION; GLAUCOMA, OPEN-ANGLE; GLUTATHIONE TRANSFERASE; HAPLOTYPES; HUMANS; MATRIX METALLOPROTEINASE 1; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ADENOSINE A3;

EID: 84876552388     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-6-22     Document Type: Review

References (80)

1. Schlotzer-Schrehardt U, Naumann GO: Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 2006, 141(5):921-937.
2. Schlotzer-Schrehardt UM, Koca MR, Naumann GO, Volkholz H: Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol 1992, 110(12):1752-1756.
3. Streeten BW, Li ZY, Wallace RN, Eagle RC Jr, Keshgegian AA: Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 1992, 110(12):1757-1762.
4. Schlotzer-Schrehardt U, Kuchle M, Hofmann-Rummelt C, Kaiser A, Kirchner T: Latent TGF-beta 1 binding protein (LTBP-1); a new marker for intra-and extraocular PEX deposits. Klin Monbl Augenheilkd 2000, 216(6):412-419.
5. Mitchell P, Wang JJ, Smith W: Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 1997, 124(5):685-687.
6. Schumacher S, Schlotzer-Schrehardt U, Martus P, Lang W, Naumann GO: Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet 2001, 357(9253):359-360.
7. Ritland JS, Egge K, Lydersen S, Juul R, Semb SO: Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity. Acta Ophthalmol Scand 2004, 82(4):401-404.
8. Allingham RR, Loftsdottir M, Gottfredsdottir MS, Thorgeirsson E, Jonasson F, Sverisson T, Hodge WG, Damji KF, Stefánsson E: Pseudoexfoliation syndrome in Icelandic families. Br J Ophthalmol 2001, 85(6):702-707.
9. Conway RM, Schlotzer-Schrehardt U, Kuchle M, Naumann GO: Pseudoexfoliation syndrome: pathological manifestations of relevance to intraocular surgery. Clin Experiment Ophthalmol 2004, 32(2):199-210.
10. Vogt A: Ein neues Spaltlampenbild des Pupillengebiets: Hellblauer Pupillensaumfilz mit Häutchenbildung auf der Linsenvorderkapsel. Klein Monatsbl Augenheilkd 1925, 75:1-12.
11. Ritch R, Schlotzer-Schrehardt U: Exfoliation (pseudoexfoliation) syndrome: toward a new understanding. Proceedings of the First International Think Tank. Acta Ophthalmol Scand 2001, 79(2):213-217.
12. Schlotzer-Schrehardt U, von der Mark K, Sakai LY, Naumann GO: Increased extracellular deposition of fibrillin-containing fibrils in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 1997, 38(5):970-984.
13. Ovodenko B, Rostagno A, Neubert TA, Shetty V, Thomas S, Yang A, Liebmann J, Ghiso J, Ritch R: Proteomic analysis of exfoliation deposits. Invest Ophthalmol Vis Sci 2007, 48(4):1447-1457.
14. Zenkel M, Kruse FE, Junemann AG, Naumann GO, Schlotzer-Schrehardt U: Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material. Invest Ophthalmol Vis Sci 2006, 47(5):1982-1990.
15. Schlotzer-Schrehardt U, Lommatzsch J, Kuchle M, Konstas AG, Naumann GO: Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2003, 44(3):1117-1125.
16. Ho SL, Dogar GF, Wang J, Crean J, Wu QD, Oliver N, Weitz S, Murray A, Cleary PE, O'Brien C: Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome. Br J Ophthalmol 2005, 89(2):169-173.
17. Ronkko S, Rekonen P, Kaarniranta K, Puustjarvi T, Terasvirta M, Uusitalo H: Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol 2007, 245(5):697-704.
18. Mitchell P, Wang JJ, Hourihan F: The relationship between glaucoma and pseudoexfoliation: the Blue Mountains Eye Study. Arch Ophthalmol 1999, 117(10):1319-1324.
19. Gottanka J, Kuhlmann A, Scholz M, Johnson DH, Lutjen-Drecoll E: Pathophysiologic changes in the optic nerves of eyes with primary open angle and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 2005, 46(11):4170-4181.
20. Arnarsson AM: Epidemiology of exfoliation syndrome in the Reykjavik Eye Study. Acta Ophthalmol 2009, 87(Thesis 3):1-17.
21. Aasved H: Study of relatives of persons with fibrillopathia epitheliocapsularis (pseudoexfoliation of the lens capsule). Acta Ophthalmol (Copenh) 1975, 53(6):879-886.
22. Ritch R: Exfoliation syndrome: clinical findings and occurrence in patients with occludable angles. Trans Am Ophthalmol Soc 1994, 92:845-944.
23. Sood GC, Sofat BK, Mehrotra SK, Chandel RD: Capsular exfoliation syndrome. Br J Ophthalmol 1973, 57(2):120-124.
24. Damji KF, Bains HS, Amjadi K, Dohadwala AA, Valberg JD, Chevrier R, Gould LF, Zackon DH, Addison DJ: Familial occurrence of pseudoexfoliation in Canada. Can J Ophthalmol 1999, 34(5):257-265.
25. Klouman OF: Psuedoexfoliation in ophthalmic practice. Acta Ophthalmol (Copenh) 1967, 45(6):822-828.
26. FitzSimon JS, Mulvihill A, Kennedy S, Finch A, Collum LM, Eustace P: Association of HLA type with pseudoexfoliation of the lens capsule. Br J Ophthalmol 1996, 80(5):402-404.
27. Lemmela S, Forsman E, Sistonen P, Eriksson A, Forsius H, Jarvela I: Genome-wide scan of exfoliation syndrome. Invest Ophthalmol Vis Sci 2007, 48(9):4136-4142.
28. Thorleifsson G, Magnusson KP, Sulem P, Walters GB, Gudbjartsson DF, Stefansson H, Jonsson T, Jonasdottir A, Jonasdottir A, Stefansdottir G, Masson G, Hardarson GA, Petursson H, Arnarsson A, Motallebipour M, Wallerman O, Wadelius C, Gulcher JR, Thorsteinsdottir U, Kong A, Jonasson F, Stefansson K: Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 2007, 317(5843):1397-1400.
29. Ozaki M, Lee KY, Vithana EN, Yong VH, Thalamuthu A, Mizoguchi T, Venkatraman A, Aung T: Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese. Invest Ophthalmol Vis Sci 2008, 49(9):3976-3980.
30. Ramprasad VL, George R, Soumittra N, Sharmila F, Vijaya L, Kumaramanickavel G: Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India. Mol Vis 2008, 14:318-322.
31. Hayashi H, Gotoh N, Ueda Y, Nakanishi H, Yoshimura N: Lysyl oxidase-like 1 polymorphisms and exfoliation syndrome in the Japanese population. Am J Ophthalmol 2008, 145(3):582-585.
32. Chen L, Jia L, Wang N, Tang G, Zhang C, Fan S, Liu W, Meng H, Zeng W, Liu N, Wang H, Jia H: Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population. Mol Vis 2009, 15:2349-2357.
33. Williams SE, Whigham BT, Liu Y, Carmichael TR, Qin X, Schmidt S, Ramsay M, Hauser MA, Allingham RR: Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population. Mol Vis 2010, 16:705-712.
34. Challa P, Schmidt S, Liu Y, Qin X, Vann RR, Gonzalez P, Allingham RR, Hauser MA: Analysis of LOXL1 polymorphisms in a United States population with pseudoexfoliation glaucoma. Mol Vis 2008, 14:146-149.
35. Csiszar K: Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol 2001, 70:1-32.
36. Decitre M, Gleyzal C, Raccurt M, Peyrol S, Aubert-Foucher E, Csiszar K, Sommer P: Lysyl oxidase-like protein localizes to sites of de novo fibrinogenesis in fibrosis and in the early stromal reaction of ductal breast carcinomas. Lab Invest 1998, 78(2):143-151.
37. Liu X, Zhao Y, Gao J, Pawlyk B, Starcher B, Spencer JA, Yanagisawa H, Zuo J, Li T: Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet 2004, 36(2):178-182.
38. Kielty CM, Wess TJ, Haston L, Ashworth JL, Sherratt MJ, Shuttleworth CA: Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix. J Muscle Res Cell Motil 2002, 23(5-6):581-596.
39. Thomassin L, Werneck CC, Broekelmann TJ, Gleyzal C, Hornstra IK, Mecham RP, Sommer P: The pro-regions of lysyl oxidase and lysyl oxidase-like 1 are required for deposition onto elastic fibers. J Biol Chem 2005, 280(52):42848-42855.
40. Yu HG, Liu X, Kiss S, Connolly E, Gragoudas ES, Michaud NA, Bulgakov OV, Adamian M, DeAngelis MM, Miller JW, Li T, Kim IK: Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1. Invest Ophthalmol Vis Sci 2008, 49(6):2599-2605.
41. Ward DM, Shiflett SL, Kaplan J: Chediak-Higashi syndrome: a clinical and molecular view of a rare lysosomal storage disorder. Curr Mol Med 2002, 2(5):469-477.
42. Trantow CM, Mao M, Petersen GE, Alward EM, Alward WL, Fingert JH, Anderson MG: Lyst mutation in mice recapitulates iris defects of human exfoliation syndrome. Invest Ophthalmol Vis Sci 2009, 50(3):1205-1214.
43. Oleggini R, Gastaldo N, Di Donato A: Regulation of elastin promoter by lysyl oxidase and growth factors: cross control of lysyl oxidase on TGF-beta1 effects. Matrix Biol 2007, 26(6):494-505.
44. Burdon KP, Sharma S, Hewitt AW, McMellon AE, Wang JJ, Mackey DA, Mitchell P, Craig JE: Genetic analysis of the clusterin gene in pseudoexfoliation syndrome. Mol Vis 2008, 14:1727-1736.
45. Schlotzer-Schrehardt U, Zenkel M, Decking U, Haubs D, Kruse FE, Jünemann A, Coca-Prados M, Naumann GO: Selective upregulation of the A3 adenosine receptor in eyes with pseudoexfoliation syndrome and glaucoma. Invest Ophthalmol Vis Sci 2005, 46(6):2023-2034.
46. Vessani RM, Ritch R, Liebmann JM, Jofe M: Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol 2003, 136(1):41-46.
47. Turacli ME, Tekeli O, Ozdemir F, Akar N: Methylenetetrahydrofolate reductase 677 C-T and homocysteine levels in Turkish patients with pseudoexfoliation. Clin Experiment Ophthalmol 2005, 33(5):505-508.
48. Fan BJ, Chen T, Grosskreutz C, Pasquale L, Rhee D, DelBono E, Haines JL, Wiggs JL: Lack of association of polymorphisms in homocysteine metabolism genes with pseudoexfoliation syndrome and glaucoma. Mol Vis 2008, 14:2484-2491.
49. Gartaganis SP, Georgakopoulos CD, Mela EK, Exarchou A, Ziouti N, Assouti M, Vynios DH: Matrix metalloproteinases and their inhibitors in exfoliation syndrome. Ophthalmic Res 2002, 34(3):165-171.
50. Mannervik B, Danielson UH: Glutathione transferases-structure and catalytic activity. CRC Crit Rev Biochem 1988, 23(3):283-337.
51. Bekris LM, Shephard C, Peterson M, Hoehna J, Van Yserloo B, Rutledge E, Farin F, Kavanagh TJ, Lernmark A: Glutathione-s-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset. Autoimmunity 2005, 38(8):567-575.
52. Izzotti A, Bagnis A, Sacca SC: The role of oxidative stress in glaucoma. Mutat Res 2006, 612(2):105-114.
53. Taylor A, Nowell T: Oxidative stress and antioxidant function in relation to risk for cataract. Adv Pharmacol 1997, 38:515-536.
54. Beatty S, Koh H, Phil M, Henson D, Boulton M: The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000, 45(2):115-134.
55. Unal M, Guven M, Devranoglu K, Ozaydin A, Batar B, Tamçelik N, Görgün EE, Uçar D, Sarici A: Glutathione S transferase M1 and T1 genetic polymorphisms are related to the risk of primary open-angle glaucoma: a study in a Turkish population. Br J Ophthalmol 2007, 91(4):527-530.
56. Khan MI, Micheal S, Akhtar F, Ahmed W, Ijaz B, Ahmed A, Qamar R: The association of glutathione S-transferase GSTT1 and GSTM1 gene polymorphism with pseudoexfoliative glaucoma in a Pakistani population. Mol Vis 2010, 16:2146-2152.
57. Abu-Amero KK, Morales J, Mohamed GH, Osman MN, Bosley TM: Glutathione S-transferase M1 and T1 polymorphisms in Arab glaucoma patients. Mol Vis 2008, 14:425-430.
58. Krumbiegel M, Pasutto F, Schlotzer-Schrehardt U, Uebe S, Zenkel M, Mardin CY, Weisschuh N, Paoli D, Gramer E, Becker C, Ekici AB, Weber BH, Nürnberg P, Kruse FE, Reis A: Genome-wide association study with DNA pooling identifies variants at CNTNAP2 associated with pseudoexfoliation syndrome. Eur J Hum Genet 2011, 19(2):186-193.
59. Poliak S, Peles E: The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci 2003, 4(12):968-980.
60. Einheber S, Zanazzi G, Ching W, Scherer S, Milner TA, Peles E, Salzer JL: The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J Cell Biol 1997, 139(6):1495-1506.
61. Yan X, Tezel G, Wax MB, Edward DP: Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch Ophthalmol 2000, 118(5):666-673.
62. Khan MI, Micheal S, Rana N, Akhtar F, den Hollander AI, Ahmed A, Qamar R: Association of tumor necrosis factor alpha gene polymorphism G-308A with pseudoexfoliative glaucoma in the Pakistani population. Mol Vis 2009, 15:2861-2867.
63. Huang P, Zhang SS, Zhang C: The two sides of cytokine signaling and glaucomatous optic neuropathy. J Ocul Biol Dis Infor 2009, 2(2):78-83.
64. Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, She H, Michaud N, Hafezi-Moghadam A, Miller JW, Benowitz LI: Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci 2006, 26(49):12633-12641.
65. Razeghinejad MR, Rahat F, Kamali-Sarvestani E: Association of TNFA -308 G/A and TNFRI +36 A/G gene polymorphisms with glaucoma. Ophthalmic Res 2009, 42(3):118-124.
66. Tekeli O, Turacli ME, Egin Y, Akar N, Elhan AH: Tumor necrosis factor alpha-308 gene polymorphism and pseudoexfoliation glaucoma. Mol Vis 2008, 14:1815-1818.
67. Mossbock G, Renner W, El-Shabrawi Y, Faschinger C, Schmut O, Wedrich A, Zimmermann C, Weger M: TNF-alpha -308 G > A and -238 G > A polymorphisms are not major risk factors in Caucasian patients with exfoliation glaucoma. Mol Vis 2009, 15:518-522.
68. Khan MI, Micheal S, Akhtar F, Naveed A, Ahmed A, Qamar R: Association of ABO blood groups with glaucoma in the Pakistani population. Can J Ophthalmol 2009, 44(5):582-586.
69. Zaree REY, Fakhraie G, Ghannadi F, Varmazyar R: Association between glaucoma and blood groups. Acta Med Iran 2006, 44:329-332.
70. Damji KF, Bains HS, Stefansson E, Loftsdottir M, Sverrisson T, Thorgeirsson E, Jonasson F, Gottfredsdottir M, Allingham RR: Is pseudoexfoliation syndrome inherited? A review of genetic and nongenetic factors and a new observation. Ophthalmic Genet 1998, 19(4):175-185.
71. Resnikoff S, Filliard G, Dell'Aquila B: Climatic droplet keratopathy, exfoliation syndrome, and cataract. Br J Ophthalmol 1991, 75(12):734-736.
72. Luntz MH TE, Ballard R: M. C. Pseudoexfoliation of the lens. Ann Inst Barraquer 1979, 14:514-529.
73. Ringvold A: Exfoliation syndrome immunological aspects. Acta Ophthalmol Suppl 1988, 184:35-43.
74. Kuchle M, Naumann GO: Occurrence of pseudoexfoliation following penetrating keratoplasty for keratoconus. Br J Ophthalmol 1992, 76(2):98-100.
75. Konstas AG, Ritch R, Bufidis T, Morales J, Qi Y, Streeten BW: Exfoliation syndrome in a 17-year-old girl. Arch Ophthalmol 1997, 115(8):1063-1067.
76. Horven I, Hutchinson BT: Exfoliation syndrome. Case reports of 31 and 35-year-old patients. Acta Ophthalmol (Copenh) 1967, 45(3):294-298.
77. Lee KY, Ho SL, Thalamuthu A, Venkatraman A, Venkataraman D, Pek DC, Aung T, Vithana EN: Association of LOXL1 polymorphisms with pseudoexfoliation in the Chinese. Mol Vis 2009, 15:1120-1126.
78. Pasutto F, Krumbiegel M, Mardin CY, Paoli D, Lämmer R, Weber BH, Kruse FE, Schlötzer-Schrehardt U, Reis A: Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 2008, 49(4):1459-1463.
79. Hewitt AW, Sharma S, Burdon KP, Wang JJ, Baird PN, Dimasi DP, Mackey DA, Mitchell P, Craig JE: Ancestral LOXL1 variants are associated with pseudoexfoliation in Caucasian Australians but with markedly lower penetrance than in Nordic people. Hum Mol Genet 2008, 17(5):710-716.
80. Abu-Amero KK, Osman EA, Dewedar AS, Schmidt S, Allingham RR, Al-Obeidan SA: Analysis of LOXL1 polymorphisms in a Saudi Arabian population with pseudoexfoliation glaucoma. Mol Vis 2010, 16:2805-2810.